Harvard Medical School-ko ikertzaileekin lankidetzan egindako argitalpenak (1)

2005

  1. Cellular and molecular surrogate markers to monitor targeted and non-targeted antiangiogenic drug activity and determine optimal biologic dose

    Current Cancer Drug Targets, Vol. 5, Núm. 7, pp. 551-559